1078 related articles for article (PubMed ID: 28885774)
1. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
2. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Park KM; Song GW; Jung DH; Kim BS; Moon KM
Transplant Proc; 2007 Jun; 39(5):1526-9. PubMed ID: 17580180
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
4. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma: Korean experience.
Lee S; Ahn C; Ha T; Moon D; Choi K; Song G; Chung D; Park G; Yu Y; Choi N; Kim K; Kim K; Hwang S
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542
[TBL] [Abstract][Full Text] [Related]
6. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
7. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
8. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
12. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
13. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
15. Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review.
Parente A; Cho HD; Kim KH; Schlegel A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047199
[TBL] [Abstract][Full Text] [Related]
16. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
17. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
Bhangui P; Vibert E; Majno P; Salloum C; Andreani P; Zocrato J; Ichai P; Saliba F; Adam R; Castaing D; Azoulay D
Hepatology; 2011 May; 53(5):1570-9. PubMed ID: 21520172
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
19. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
Lee S; Song GW; Kim KW; Kwon JH; Lee SG
Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
